Hair News and Research

RSS

Merck's ZIOPTAN for reducing elevated IOP receives FDA approval

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has approved ZIOPTANTM (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution.

13 Feb 2012

Communities with small, locally-owned businesses have healthier populations

Counties and parishes with a greater concentration of small, locally-owned businesses have healthier populations - with lower rates of mortality, obesity and diabetes - than do those that rely on large companies with "absentee" owners, according to a national study by sociologists at LSU and Baylor University.

8 Feb 2012

Scientists uncover genes that govern male and female behaviors

Hormones shape our bodies, make us fertile, excite our most basic urges, and as scientists have known for years, they govern the behaviors that separate men from women. But how? Now a team of scientists at the University of California, San Francisco (UCSF) has uncovered many genes influenced by the male and female sex hormones testosterone and estrogen that, in turn, govern several specific types of male and female behaviors in mice.

3 Feb 2012

AACS 2012 announces record attendance at annual scientific meeting

The American Academy of Cosmetic Surgery (AACS) announced its highest attendance in the Academy’s history with more than 700 medical professionals at its 28th Annual Scientific Meeting. The event was held January 18-21, 2012 at Caesars Palace Hotel in Las Vegas.

1 Feb 2012

Roche’s skin cancer drug Erivedge gets FDA nod

The Food and Drugs Administration (FDA) this Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.

31 Jan 2012

Genentech receives FDA approval for Erivedge to treat basal cell carcinoma

Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body.

31 Jan 2012

CDC publishes an in-depth analysis of Mogellons disease

Experts explain that Morgellons is not an official diagnosis but a syndrome of unexplained symptoms including abnormal sensations that sufferers describe as the feeling of insects crawling on the skin. Symptoms also include fatigue. And, perhaps most peculiarly, one symptom is tiny fibers found embedded in waxy scabs on the skin.

29 Jan 2012

Home oxygen safety tips from Wake Forest Baptist

The increasing use of home oxygen over the past decade has increased the number of patients suffering from burn injuries that the Burn Center at Wake Forest Baptist Medical Center has treated.

27 Jan 2012

Experts comment on successful stem cell therapy for blindness

According to a new study published in The Lancet, privately funded and led by UCLA and Advanced Cell Technology researchers, two women suffering a progressive form of blindness have shown improved vision.

24 Jan 2012

Loyola hand surgeon restores circulation and function of thumb and index finger

Tom Thompson nearly lost his left thumb and index finger in a power saw injury, but Loyola University Medical Center hand surgeon Dr. Randy Bindra was able to restore circulation and function to the mangled digits in a delicate 5½ hour surgery.

24 Jan 2012

New sensor can detect glucose levels in human saliva

For the 26 million Americans with diabetes, drawing blood is the most prevalent way to check glucose levels. It is invasive and at least minimally painful. Researchers at Brown University are working on a new sensor that can check blood sugar levels by measuring glucose concentrations in saliva instead.

24 Jan 2012

Researchers create first 3D structure of key cancer protein

Cancer Research UK scientists have created the first 3D structure of a key protein that protects against the development of cancer, according to research published in Nature Structural & Molecular Biology today.

22 Jan 2012

UHCMC now offers HITEC for women with gynecologic cancers

Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.

21 Jan 2012

Researchers discover HS1.2 enhancer as the cause of SLE

A "genetic accelerator" is responsible for the most severe cases of Lupus (systemic lupus erythemathosus), an autoimmune disease: the accelerator, called enhancer HS1.2, speeds up the activity of some critical genes of the immune system involved in the disease.

17 Jan 2012

Scientists discover how sense of touch is wired in skin and nervous system

Neuroscientists at the Johns Hopkins University School of Medicine have discovered how the sense of touch is wired in the skin and nervous system. The new findings, published Dec. 22 in Cell, open new doors for understanding how the brain collects and processes information from hairy skin.

12 Jan 2012

Researchers use 3-D imaging to identify proteins involved in arterial stiffness

Human arteries - some smaller than a strand of hair - stiffen as a person ages. This stiffening is a factor in cardiovascular disease, the leading cause of death in the United States, because it contributes to the circulatory complications in disorders such as high blood pressure and diabetes. University of Missouri researchers have now used advanced 3-D microscopic imaging technology to identify and monitor the proteins involved in this stiffening process.

10 Jan 2012

Fallujah doctors say chemicals from U.S. weapons to blame for high levels of birth defects

"While the U.S. military has formally withdrawn from Iraq, doctors and residents of Fallujah are blaming weapons like depleted uranium and white phosphorous used during two devastating U.S. attacks on Fallujah in 2004 for what are being described as 'catastrophic' levels of birth defects and abnormalities," Al Jazeera reports.

10 Jan 2012

AB receives TÜV approval for Neptune waterproof sound processor in Europe

Advanced Bionics (AB), the global leader in cochlear implant technology, announced today that it received approval in Europe for Neptune, the world's first and only swimmable, waterproof sound processor.

7 Jan 2012

Research reveals how bats parse duties at single neuron level

Imagine listening to music while carrying on a conversation with friends. This type of multi-tasking is fairly easy to do, right? That's because our brains efficiently and effectively separate the auditory signals - music to the right side; conversation to the left. But what researchers have not been able to do in humans or animals is to see a parsing of duties at the single neuron level - until now.

4 Jan 2012

Researchers identify gene required for proper development of mouse inner ear

Providing clues to deafness, researchers at Washington University School of Medicine in St. Louis have identified a gene that is required for proper development of the mouse inner ear.

4 Jan 2012